TAK-981

Research use only, not for human use.

TAK-981 is a selective the SUMOylation enzymatic cascade inhibitor, has potential immune-activating and antineoplastic activities.

TAK-981 is a selective the SUMOylation enzymatic cascade inhibitor, has potential immune-activating and antineoplastic activities. (In Vitro):Subasumstat (TAK-981) is able to increase the production of type 1 IFN, thereby increasing type 1 IFN-mediated signaling, activating innate effector cells and enhancing the antitumor innate immune responses.(In Vivo):A single sub-cutaneous injection of Subasumstat (TAK-981) in naive Balb/c mice at the brachial lymph nodes induces activation of DCs.

——

——

Subasumstat

Others

Other Targets

SUMOylation

——

——

1858276-04-6

578.1

C25H28ClN5O5S2

>98% (HPLC)

DMSO:75 mg/mL (129.74 mM; Need ultrasonic)

Cc1c([C@@H]2NCCc(cc3)c2cc3Cl)cc(C(c2c(N[C@H](C[C@@H]3COS(N)(=O)=O)C[C@@H]3O)ncnc2)=O)s1

——

(-20℃)

With Ice Pack

≥ 2 years